Medicaid’s Next Performance Test: Can Plans Reach the Members They’re Accountable For?
For many of Medicaid’s highest-need members, the problem isn’t that services don’t exist. It’s that the system can’t consistently reach the people who need those services most.
Stop the Revolving Door: Why Five-Year Contracts are the Key to Saving Medicare Advantage
To truly deliver on the promise of proactive, preventive care for seniors with complex, chronic conditions, we should move away from the current one-year open enrollment cycle and toward a five-year contract period.
Handspring Snags $19M to Fix the “Missing Middle” of Youth Mental Health Care
Handspring raised $19 million in Series B funding this week to expand its pediatric mental health care model nationwide. The company treats the full spectrum of acuity so children are matched to the level of care they actually need, rather than defaulting to the most intensive — and expensive — option available.
UHC Unveils New Employer-Sponsored Spending Account Benefit
UnitedHealthcare introduced a Lifestyle Spending Account that gives employers more flexibility to fund employees' health and wellness expenses.
Glaucoma Drug Fails Trial, But Bausch + Lomb Sees Opportunity in Another Eye Disease
A Bausch + Lomb drug from a 2025 acquisition missed primary and secondary goals of a Phase 2 test in glaucoma. Bausch now plans to develop this drug for geographic atrophy, aiming to succeed where Allergan, now an AbbVie subsidiary, fell short in the clinic.